Overall, there are two paradigms of signaling to be targeted in regards to PXR activation 1) PXR-mediated signaling in drug metabolism and 2) PXR-mediated signaling in cell proliferation, apoptosis and tumor aggressiveness, which opens numerous avenues for targeted therapeutic application. The gene discussed is NR1I2; the disease is neoplasm.